FIELD: biotechnologies.
SUBSTANCE: blood is separated into plasma and cellular fraction. Then the blood cellular fraction is subjected to successive two-phase treatment first by the buffer PBS solution containing 5 mM of EDTA with subsequent centrifugation and collection of supernatant. Cells are treated by equal volume of 0.15-0.35% trypsin solution in PBS with subsequent centrifugation and collection of supernatant. Plasma and extracted supernatants from cellular fraction are merged, cellular debris is removed by centrifugation at 15000-17000 g within 10-20 minutes. Foreign particles of non-exosome origin by filtration through filters with the diameter pores 0.1 mcm, and the total pool of exosomes is settled by ultracentrifugation at 100000-160000 g during 60-120 minutes.
EFFECT: invention allows to increase yield and purity of target product, reduce duration and labour input of the method.
3 cl, 2 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC AND MONITORING TECHNIQUE FOR ONCOLOGY DISEASES WITH USE OF BLOOD EXOSOMES | 2014 |
|
RU2571507C1 |
METHOD OF OBTAINING BLOOD EXOSOMES | 2016 |
|
RU2608509C1 |
METHOD OF MICROVESICULES INSULATION FROM BLOOD | 2017 |
|
RU2651521C1 |
METHOD FOR ISOLATING EXOSOMES FROM CONDITIONED CELL CULTURE MEDIUM | 2020 |
|
RU2750928C1 |
METHOD FOR PLASMA EXOSOME RELEASE | 2020 |
|
RU2741776C1 |
EXOSOMES AND THEIR USE AS VACCINE | 2016 |
|
RU2763524C2 |
METHOD FOR ISOLATING EXTRACELLULAR VESICLES FROM BIOLOGICAL FLUIDS | 2018 |
|
RU2678988C1 |
METHOD FOR DIAGNOSING MELANOMA USING EXOSOMAL microRNA | 2020 |
|
RU2769927C2 |
EXTRACELLULAR VESICLES FOR INHALATION | 2019 |
|
RU2799315C2 |
METHOD OF DETERMINING THE RISK OF MALIGNANT TRANSFORMATION OF PROSTATE CELLS | 2022 |
|
RU2806518C1 |
Authors
Dates
2015-07-20—Published
2014-09-15—Filed